HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-AUG-13 4MF1 TITLE ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR 12B (1S,2S)- TITLE 2 2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-1,3- TITLE 3 BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ITK/TSK; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 357-620; COMPND 5 SYNONYM: INTERLEUKIN-2-INDUCIBLE T-CELL KINASE, IL-2-INDUCIBLE T-CELL COMPND 6 KINASE, KINASE EMT, T-CELL-SPECIFIC KINASE, TYROSINE-PROTEIN KINASE COMPND 7 LYK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EMT, ITK, LYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROTEIN KINASE, PHOSPHOTRANSFER CATALYST, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.EIGENBROT,S.SHIA REVDAT 3 28-FEB-24 4MF1 1 REMARK SEQADV REVDAT 2 20-NOV-13 4MF1 1 JRNL REVDAT 1 13-NOV-13 4MF1 0 JRNL AUTH C.H.MACKINNON,K.LAU,J.D.BURCH,Y.CHEN,J.DINES,X.DING, JRNL AUTH 2 C.EIGENBROT,A.HEIFETZ,A.JAOCHICO,A.JOHNSON,J.KRAEMER, JRNL AUTH 3 S.KRUGER,T.M.KRULLE,M.LIIMATTA,J.LY,R.MAGHAMES, JRNL AUTH 4 C.A.MONTALBETTI,D.F.ORTWINE,Y.PEREZ-FUERTES,S.SHIA, JRNL AUTH 5 D.B.STEIN,G.TRANI,D.G.VAIDYA,X.WANG,S.M.BROMIDGE,L.C.WU, JRNL AUTH 6 Z.PEI JRNL TITL STRUCTURE-BASED DESIGN AND SYNTHESIS OF POTENT BENZOTHIAZOLE JRNL TITL 2 INHIBITORS OF INTERLEUKIN-2 INDUCIBLE T CELL KINASE (ITK). JRNL REF BIOORG.MED.CHEM.LETT. V. 23 6331 2013 JRNL REFN ISSN 0960-894X JRNL PMID 24138940 JRNL DOI 10.1016/J.BMCL.2013.09.069 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.3_928) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 26887 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.210 REMARK 3 FREE R VALUE TEST SET COUNT : 864 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.8840 - 3.8450 0.98 4512 160 0.1670 0.1950 REMARK 3 2 3.8450 - 3.0529 0.97 4498 144 0.1634 0.2224 REMARK 3 3 3.0529 - 2.6673 0.98 4516 150 0.1843 0.2230 REMARK 3 4 2.6673 - 2.4235 0.98 4556 125 0.1783 0.2948 REMARK 3 5 2.4235 - 2.2499 0.95 4377 135 0.1846 0.2204 REMARK 3 6 2.2499 - 2.1173 0.77 3564 150 0.2067 0.3015 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.86 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 42.53 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.840 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.24650 REMARK 3 B22 (A**2) : -4.22220 REMARK 3 B33 (A**2) : 2.97570 REMARK 3 B12 (A**2) : 0.87670 REMARK 3 B13 (A**2) : -5.63150 REMARK 3 B23 (A**2) : -8.37310 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4039 REMARK 3 ANGLE : 1.013 5460 REMARK 3 CHIRALITY : 0.073 591 REMARK 3 PLANARITY : 0.004 692 REMARK 3 DIHEDRAL : 14.520 1466 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MF1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000081828. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : ASYMMETRIC CURVED CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26887 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.130 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06200 REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6000, 0.2M NACL, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 292K, PH 6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS TWO KINASE DOMAINS. THE REMARK 300 ACTIVITY BIOLOGICAL ASSEMBLY IS UNDERSTOOD TO BE A SINGLE KINASE REMARK 300 DOMAIN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 373 REMARK 465 PHE A 374 REMARK 465 ARG A 394 REMARK 465 GLU A 395 REMARK 465 GLY A 396 REMARK 465 THR A 504 REMARK 465 ARG A 505 REMARK 465 PHE A 506 REMARK 465 VAL A 507 REMARK 465 LEU A 508 REMARK 465 ASP A 509 REMARK 465 ASP A 510 REMARK 465 GLN A 511 REMARK 465 TYR A 512 REMARK 465 THR A 513 REMARK 465 SER A 514 REMARK 465 SER A 515 REMARK 465 THR A 516 REMARK 465 GLY A 517 REMARK 465 THR A 518 REMARK 465 LYS A 519 REMARK 465 PHE A 520 REMARK 465 LEU A 620 REMARK 465 GLN B 373 REMARK 465 PHE B 374 REMARK 465 ARG B 394 REMARK 465 GLU B 395 REMARK 465 GLY B 396 REMARK 465 PHE B 506 REMARK 465 VAL B 507 REMARK 465 LEU B 508 REMARK 465 ASP B 509 REMARK 465 ASP B 510 REMARK 465 GLN B 511 REMARK 465 TYR B 512 REMARK 465 THR B 513 REMARK 465 SER B 514 REMARK 465 SER B 515 REMARK 465 THR B 516 REMARK 465 GLY B 517 REMARK 465 THR B 518 REMARK 465 LYS B 519 REMARK 465 LEU B 620 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS B 523 O HOH B 834 2.05 REMARK 500 OE2 GLU B 362 O HOH B 927 2.19 REMARK 500 O HIS A 440 O HOH A 862 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 369 15.78 -158.79 REMARK 500 ASN A 384 29.34 49.44 REMARK 500 LYS A 385 -65.60 -129.21 REMARK 500 MET A 398 133.20 157.10 REMARK 500 ARG A 481 -14.67 81.24 REMARK 500 ASP A 482 45.30 -146.53 REMARK 500 ASN A 561 13.54 57.18 REMARK 500 VAL B 366 -62.82 -91.06 REMARK 500 LYS B 385 -70.47 -132.04 REMARK 500 MET B 398 155.98 174.70 REMARK 500 ARG B 481 -15.78 79.01 REMARK 500 ASP B 482 44.75 -142.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 29Y A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 29Y B 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MF0 RELATED DB: PDB DBREF 4MF1 A 357 620 UNP Q08881 ITK_HUMAN 357 620 DBREF 4MF1 B 357 620 UNP Q08881 ITK_HUMAN 357 620 SEQADV 4MF1 GLY A 355 UNP Q08881 EXPRESSION TAG SEQADV 4MF1 SER A 356 UNP Q08881 EXPRESSION TAG SEQADV 4MF1 SER A 477 UNP Q08881 CYS 477 ENGINEERED MUTATION SEQADV 4MF1 ALA A 614 UNP Q08881 GLU 614 ENGINEERED MUTATION SEQADV 4MF1 ALA A 617 UNP Q08881 GLU 617 ENGINEERED MUTATION SEQADV 4MF1 GLY B 355 UNP Q08881 EXPRESSION TAG SEQADV 4MF1 SER B 356 UNP Q08881 EXPRESSION TAG SEQADV 4MF1 SER B 477 UNP Q08881 CYS 477 ENGINEERED MUTATION SEQADV 4MF1 ALA B 614 UNP Q08881 GLU 614 ENGINEERED MUTATION SEQADV 4MF1 ALA B 617 UNP Q08881 GLU 617 ENGINEERED MUTATION SEQRES 1 A 266 GLY SER VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN SEQRES 2 A 266 GLU ILE GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY SEQRES 3 A 266 TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE SEQRES 4 A 266 ARG GLU GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU SEQRES 5 A 266 ALA GLU VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL SEQRES 6 A 266 GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS SEQRES 7 A 266 LEU VAL PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP SEQRES 8 A 266 TYR LEU ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR SEQRES 9 A 266 LEU LEU GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA SEQRES 10 A 266 TYR LEU GLU GLU ALA SER VAL ILE HIS ARG ASP LEU ALA SEQRES 11 A 266 ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS SEQRES 12 A 266 VAL SER ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP SEQRES 13 A 266 GLN TYR THR SER SER THR GLY THR LYS PHE PRO VAL LYS SEQRES 14 A 266 TRP ALA SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SEQRES 15 A 266 SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 16 A 266 GLU VAL PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SEQRES 17 A 266 SER ASN SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE SEQRES 18 A 266 ARG LEU TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR SEQRES 19 A 266 GLN ILE MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP SEQRES 20 A 266 ARG PRO ALA PHE SER ARG LEU LEU ARG GLN LEU ALA ALA SEQRES 21 A 266 ILE ALA ALA SER GLY LEU SEQRES 1 B 266 GLY SER VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN SEQRES 2 B 266 GLU ILE GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY SEQRES 3 B 266 TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE SEQRES 4 B 266 ARG GLU GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU SEQRES 5 B 266 ALA GLU VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL SEQRES 6 B 266 GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS SEQRES 7 B 266 LEU VAL PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP SEQRES 8 B 266 TYR LEU ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR SEQRES 9 B 266 LEU LEU GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA SEQRES 10 B 266 TYR LEU GLU GLU ALA SER VAL ILE HIS ARG ASP LEU ALA SEQRES 11 B 266 ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS SEQRES 12 B 266 VAL SER ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP SEQRES 13 B 266 GLN TYR THR SER SER THR GLY THR LYS PHE PRO VAL LYS SEQRES 14 B 266 TRP ALA SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SEQRES 15 B 266 SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 16 B 266 GLU VAL PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SEQRES 17 B 266 SER ASN SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE SEQRES 18 B 266 ARG LEU TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR SEQRES 19 B 266 GLN ILE MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP SEQRES 20 B 266 ARG PRO ALA PHE SER ARG LEU LEU ARG GLN LEU ALA ALA SEQRES 21 B 266 ILE ALA ALA SER GLY LEU HET 29Y A 701 33 HET 29Y B 701 33 HETNAM 29Y (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H- HETNAM 2 29Y PYRAZOL-4-YL)-1,3-BENZOTHIAZOL-2- HETNAM 3 29Y YL]CYCLOPROPANECARBOXAMIDE FORMUL 3 29Y 2(C23 H23 N5 O S) FORMUL 5 HOH *280(H2 O) HELIX 1 1 ASP A 359 SER A 361 5 3 HELIX 2 2 SER A 399 MET A 411 1 13 HELIX 3 3 LEU A 443 GLN A 450 1 8 HELIX 4 4 ALA A 455 ALA A 476 1 22 HELIX 5 5 ALA A 484 ARG A 486 5 3 HELIX 6 6 GLU A 492 GLN A 494 5 3 HELIX 7 7 PRO A 521 ALA A 525 5 5 HELIX 8 8 SER A 526 SER A 533 1 8 HELIX 9 9 SER A 536 SER A 553 1 18 HELIX 10 10 SER A 563 THR A 573 1 11 HELIX 11 11 SER A 584 TRP A 595 1 12 HELIX 12 12 ARG A 598 ARG A 602 5 5 HELIX 13 13 ALA A 604 GLY A 619 1 16 HELIX 14 14 ASP B 359 SER B 361 5 3 HELIX 15 15 SER B 399 MET B 411 1 13 HELIX 16 16 LEU B 443 GLN B 450 1 8 HELIX 17 17 ALA B 455 ALA B 476 1 22 HELIX 18 18 ALA B 484 ARG B 486 5 3 HELIX 19 19 GLU B 492 GLN B 494 5 3 HELIX 20 20 PRO B 521 ALA B 525 5 5 HELIX 21 21 SER B 526 SER B 533 1 8 HELIX 22 22 SER B 536 SER B 553 1 18 HELIX 23 23 SER B 563 THR B 573 1 11 HELIX 24 24 SER B 584 TRP B 595 1 12 HELIX 25 25 ARG B 598 ARG B 602 5 5 HELIX 26 26 ALA B 604 GLY B 619 1 16 SHEET 1 A 5 LEU A 363 GLY A 370 0 SHEET 2 A 5 VAL A 377 TRP A 382 -1 O LEU A 379 N GLN A 367 SHEET 3 A 5 ASP A 386 THR A 392 -1 O ILE A 390 N HIS A 378 SHEET 4 A 5 CYS A 432 GLU A 436 -1 O LEU A 433 N LYS A 391 SHEET 5 A 5 LEU A 421 CYS A 425 -1 N TYR A 422 O VAL A 434 SHEET 1 B 3 GLY A 441 CYS A 442 0 SHEET 2 B 3 CYS A 488 VAL A 490 -1 O VAL A 490 N GLY A 441 SHEET 3 B 3 ILE A 496 VAL A 498 -1 O LYS A 497 N LEU A 489 SHEET 1 C 5 LEU B 363 GLY B 370 0 SHEET 2 C 5 LEU B 376 TRP B 382 -1 O LEU B 379 N GLN B 367 SHEET 3 C 5 ASP B 386 THR B 392 -1 O VAL B 388 N GLY B 380 SHEET 4 C 5 CYS B 432 GLU B 436 -1 O LEU B 433 N LYS B 391 SHEET 5 C 5 LEU B 421 CYS B 425 -1 N TYR B 422 O VAL B 434 SHEET 1 D 3 GLY B 441 CYS B 442 0 SHEET 2 D 3 CYS B 488 VAL B 490 -1 O VAL B 490 N GLY B 441 SHEET 3 D 3 ILE B 496 VAL B 498 -1 O LYS B 497 N LEU B 489 CISPEP 1 ALA A 429 PRO A 430 0 -3.72 CISPEP 2 ALA B 429 PRO B 430 0 1.09 SITE 1 AC1 12 ILE A 369 ALA A 389 LYS A 391 PHE A 435 SITE 2 AC1 12 GLU A 436 PHE A 437 MET A 438 GLU A 439 SITE 3 AC1 12 GLY A 441 LEU A 489 SER A 499 ASP A 500 SITE 1 AC2 15 ILE B 369 ALA B 389 LYS B 391 GLU B 401 SITE 2 AC2 15 PHE B 435 GLU B 436 PHE B 437 MET B 438 SITE 3 AC2 15 GLU B 439 HIS B 440 GLY B 441 LEU B 489 SITE 4 AC2 15 SER B 499 ASP B 500 HOH B 897 CRYST1 39.842 51.745 66.199 99.01 104.62 92.31 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025099 0.001011 0.006825 0.00000 SCALE2 0.000000 0.019341 0.003386 0.00000 SCALE3 0.000000 0.000000 0.015849 0.00000